Home Capital SGX Research Series: 10 in 10

Private cord blood banking pioneer Cordlife extends reach and expands breadth

Emelia Tan
Emelia Tan6/18/2021 06:31 AM GMT+08  • 9 min read
Private cord blood banking pioneer Cordlife extends reach and expands breadth
Cordlife extends reach and expands breadth.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

1. Could you elaborate on Cordlife’s business segments and each of its focus?

Established in May 2001, Cordlife Group is dedicated to safeguarding the well-being of mother and child. The group has been listed on the Mainboard of the Singapore Exchange since 2012. We are a pioneer in private cord blood banking and own the largest network of cord blood banks in Asia, with full stem cell banking facilities in six key markets — Singapore, Hong Kong, Indonesia, India, Malaysia, and the Philippines. All our facilities are accredited by AABB (formerly known as American Association of Blood Banks), with several also accredited by other leading standards organisations, such as Foundation for the Accreditation of Cellular Therapy (FACT) and College of American Pathologists (CAP).

Beyond cord blood, cord lining and cord tissue banking, we have extended our cryopreservation expertise to expanded stem cells in the Philippines and lenticules in Singapore, offering a comprehensive suite of diagnostics services for families including non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening and family genetic screening services.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now